Please use this identifier to cite or link to this item:
|Title:||Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer|
|Source:||Huang, R.Y.-J.,Chung, V.Y.,Thiery, J.P. (2012). Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer. Current Drug Targets 13 (13) : 1649-1653. ScholarBank@NUS Repository. https://doi.org/10.2174/138945012803530044|
|Abstract:||Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Discovery of novel therapeutic opportunities for EOC is important for the improvement of clinical outcome of the patients. Emerging evidence is suggesting that epithelial-mesenchymal transition (EMT) plays a crucial role in the aggressiveness in EOC including increasing migration and invasion ability, contributing to chemoresistance and cancer stem cell populations. Targeting EMT in EOC thus offers an attractive therapeutic option. © 2012 Bentham Science Publishers.|
|Source Title:||Current Drug Targets|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 8, 2018
checked on Mar 10, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.